FactorPad
Build a Better Process

Stock Risk Measures for Regenxbio Inc

A quantitative factor review as of August 31, 2021.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
face pic by Paul Alan Davis, CFA
Updated: September 04, 2021
See how we arrive at an overall risk score of 76 for RGNX below.

/ factorpad.com / stocks / f12cwn.html


An ad-free and cookie-free website.


RGNX Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Regenxbio Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how RGNX stock compares to 2,000+ US-based stocks, and to peers in the Manufacturing sector and Biological Product (except Diagnostic) Manufacturing industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.

Identity

Sector and Industry

Share Data

Shares

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f12cwn.html


RGNX stock risk
REGENXBIO INC stock beta
RGNX risk report
RGNX f12cwn
RGNX risk analysis
RGNX volatility
REGENXBIO INC credit risk
RGNX liquidity risk
RGNX leverage
RGNX valuation
RGNX systematic risk
RGNX specific risk
REGENXBIO INC volatility
RGNX analysis
RGNX financial ratio

A newly-updated free resource. Connect and refer a friend today.